FindMyKOL
Clinical trialNCT04553471CompletedInterventional

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

NCT04553471 is an interventional trial sponsored by Washington University School of Medicine. As of 21 Nov 2026, it is completed. It studies Abdominal Cancer, Pelvic Cancer and 2 more conditions. The registry lists an enrollment of 70 participants at 1 site in 1 country. The registry lists a start date of 22 Sept 2020 and a primary completion date of 30 Sept 2022. One of its registered investigators has a FindMyKOL profile.

SponsorWashington University School of Medicine →Enrollment70Abdominal CancerPelvic CancerSarcomaThoracic Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04553471
FieldValue
Registry IDNCT04553471
StatusCompleted
Study typeInterventional trial
Lead sponsorWashington University School of Medicine
Enrollment70
Registered sites1
Countries1
ConditionsAbdominal Cancer, Pelvic Cancer, Sarcoma and Thoracic Cancer
Start22 Sept 2020
Primary completion30 Sept 2022
Study completion4 May 2023
Last update posted29 Aug 2024

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a study evaluating the safety and efficacy of Lattice SBRT for patients with large tumors (≥ 4.5 cm) planning to undergo palliative radiotherapy.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Missouri, United States1 site
  • Washington University School of Medicine

    St Louis

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouri: 1 siteMO1KentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04553471

Each answer restates registry values shown on this page.

What is NCT04553471?

NCT04553471 is an interventional trial sponsored by Washington University School of Medicine. It studies Abdominal Cancer, Pelvic Cancer and 2 more conditions.

Who leads NCT04553471?

The registry names Pamela Samson, M.D. (principal investigator, Washington University School of Medicine) as the overall official.

Where does NCT04553471 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04553471 end?

The registry lists a primary completion date of 30 Sept 2022 and a study completion date of 4 May 2023. The sponsor last updated the record on 29 Aug 2024.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.